Clinical Trials Browser

Phase 3 × Myasthenia Gravis × Immunoglobulins, Intravenous × Clear all

NCT00515450 2010-07-30

Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia Gravis

Phase 3 Completed

Myasthenia Gravis